DIR | NACDS

NACDS Urges Standardized Pharmacy Performance Measures, DIR Fee Reform in Statement to Key House Committee As the House Committee on Energy and Commerce’s Health Subcommittee pursues drug-pricing reform, NACDS also pledges to work with Congress for policies that would not further undermine or complicate pharmacy reimbursement in the Part D program nor potentially harm patients’ access to affordable care

admin2021-05-04T16:25:45-04:00Categories: Press Release|Tags: Congress, DIR, Drug_Pricing, Medicare, Reimbursement|

As the House Committee on Energy and Commerce’s Health Subcommittee pursues drug-pricing reform, NACDS also pledges to work with Congress for policies that would not further undermine or complicate pharmacy reimbursement in the Part D program nor potentially harm patients’ access to affordable care

NACDS Leadership Kicks Off 2021 NACDS Annual Meeting with Emphasis on the Powerful Role of Industry in Restoring Hope, Overcoming the COVID Pandemic, and Building the Future Keyes: “We’ve shown what pharmacy can do when we work together … We will continue to serve, treat and heal the people of our country through this pandemic, and into the future”

admin2021-04-26T11:06:38-04:00Categories: Press Release|Tags: Annual_Meeting, Conferences, DIR, Pharmacy_Value, Preparedness, Reimbursement, Vaccinations|

Keyes: “We’ve shown what pharmacy can do when we work together … We will continue to serve, treat and heal the people of our country through this pandemic, and into the future.”

NACDS Seeks Collaboration on Pandemic Issues and Beyond as HHS and CMS Nominees Face Senate Finance Committee Lauds nominations of Chiquita Brooks-LaSure as CMS Administrator and Andrea Joan Palm as deputy secretary of HHS

admin2021-04-15T09:20:47-04:00Categories: Press Release|Tags: CMS, DIR, HHS, Preparedness, Vaccinations|

Lauds nominations of Chiquita Brooks-LaSure as CMS Administrator and Andrea Joan Palm as deputy secretary of HHS.

Virtual 2021 NACDS RxIMPACT Day on Capitol Hill Urges Pro-Patient, Pro-Pharmacy Issues Illuminated by Pandemic Preparedness COVID-19 vaccination speed and equity; “DIR fee” reform; organized retail crime among key topics for virtual advocacy March 3-4

admin2021-03-03T11:32:32-05:00Categories: Press Release|Tags: Congress, DIR, Preparedness, RxIMPACT, Vaccinations|

COVID-19 vaccination speed and equity; “DIR fee” reform; organized retail crime among key topics for virtual advocacy March 3-4.

NACDS Regional Chain Conference Underscores Resilience, Commitment, Community-Focus of Retail Pharmacy Throughout COVID Pandemic Virtual event brings together traditional drug and grocery chains with between four and 250 locations, and their supplier partners; features insights and collaboration on diverse health-and-wellness and front-end topics

admin2021-02-10T12:03:48-05:00Categories: Press Release|Tags: Conferences, DIR, Drug_Abuse, Pharmacy_Value, Preparedness, Regional_Chain_Conference, Reimbursement|

Virtual event brings together traditional drug and grocery chains with between four and 250 locations, and their supplier partners; features insights and collaboration on diverse health-and-wellness and front-end topics.

More than 240 Patient, Healthcare Groups Urge Congress to Reform Pharmacy “DIR Fees” This Year Congress “should not overlook the clear and present opportunity” to address reforms

admin2020-05-08T14:24:07-04:00Categories: Press Release|Tags: Congress, DIR, Reimbursement|

More than 240 entities urged Congressional leaders to act on a key reform to lower patients’ prescription drug prices at the pharmacy counter and to help prevent pharmacy closures that jeopardize access.

NACDS Op-ed in Morning Consult: DIR Fees “as Damaging to Patients and Pharmacies as Advertised” Congressional action urged as Drug Channels Institute analysis shows fees “have grown faster than most people realize” and reached a record $9.1 billion in 2019

admin2020-02-26T12:52:02-05:00Categories: Press Release|Tags: Congress, DIR, Public_Relations, Reimbursement|

NACDS' opinion piece cites a Drug Channels Institute analysis that DIR fees “have grown faster than most people realize” and reached a record $9.1 billion in 2019.